Life Sciences Clinical Data and Analytics (D&A) Platforms – Provider Compendium 2023
Provider Compendium Report

29 Aug 2023
by Chunky Satija, Nisarg Shah, Anik Dutta, Madhur Kakade, Apoorva Gupta

The pandemic accelerated the need to extract value from data due to the substantial increase in data generation from various clinical sources, characterized by high veracity, variety, and volume. As a result, the adoption of clinical Data and Analytics (D&A) platforms in clinical development has notably surged. This prompted a considerable interest in assessing their impact on clinical trials, patient care, treatment outcomes, and health system efficiency. The integration of complex clinical data sources including Electronic Health Records (EHR), Electronic Medical Records (EMR), laboratory data, Clinical Trial Management Systems (CTMS), connected devices, and Real-world Data (RWD), presents a significant challenge that the industry currently faces.

Clinical D&A platforms provide significant benefits in the realm of clinical development. These platforms enhance data management by facilitating centralized and standardized data collection from various sources, resulting in improved data quality and integrity. Real-time monitoring capabilities enable stakeholders to track trial progress, identify potential issues, and make informed decisions. Advanced analytics tools help uncover patterns, trends, and correlations within the data, providing valuable insights for optimizing trial protocols and treatment strategies.

In this compendium, we provide comprehensive and fact-based snapshots of 14 platform providers specific to clinical D&A. In addition, each provider is positioned on Everest Group’s PEAK Matrix® for comparison. The compendium will enable providers to benchmark their capabilities against their competitors, while buyers of clinical D&A platforms will be able to assess the providers based on their desired set of capabilities.

Scope

  • Industry: life sciences
  • Geography: global

Contents

In this report, we evaluate clinical D&A platform providers on their:

  • Market adoption and capabilities
  • Case studies and recent developments
  • Strengths and limitations
  • Sourcing considerations

Membership(s)

Clinical Development Technology

Sourcing and Vendor Management

 

Page Count: 109